Transgenic plants containing molecular decoys that alter protein content therein

a technology of molecular decoys and transgenic plants, which is applied in the direction of transferases, peptide sources, enzymology, etc., can solve the problems of reducing the abundance of that enzyme, reducing the production of end products, and increasing the end product of the biosynthetic pathway, so as to reduce the amount of tsnas and reduce the carcinogenic potential of such products

Inactive Publication Date: 2006-03-16
CONKLING MARK +1
View PDF96 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016] Yet another aspect of the invention concerns the reduction of the amount of TSNAs and metabolites thereof in humans who smoke, consume or otherwise ingest tobacco. This method is practiced by providing a tobacco product having a reduced amount of TSNAs, as described above, to said humans, thereby lowering the carcinogenic potential of such product in said humans.

Problems solved by technology

However, most of these processes remove other ingredients from tobacco in addition to nicotine, thereby adversely affecting the tobacco.
Where the affected enzyme naturally occurs in a rate-limiting amount (relative to the other enzymes required in the pathway), any reduction in that enzyme's abundance will decrease the production of the end product.
Conversely, if the naturally-occurring amount of enzyme is rate limiting, then any increase in the enzyme's activity will result in an increase in the biosynthetic pathway's end product.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transgenic plants containing molecular decoys that alter protein content therein
  • Transgenic plants containing molecular decoys that alter protein content therein
  • Transgenic plants containing molecular decoys that alter protein content therein

Examples

Experimental program
Comparison scheme
Effect test

example 1

Localization of Cis-Acting Element in NtOPT1 Promoter

[0073] To characterize the minimal sequence required for the NtQPT1 cis-acting element, the promoter region of the NtQPT1 gene was isolated, truncated at the 5′ end, and fused to the gene encoding β-glucuronidase (GUS) to assess function as a specific enhancer of nicotine production. The NtQPT1 gene was isolated and sequenced. The start of the transcript was determined by comparing the TobRD2 cDNA sequence to the genomic locus sequence. Sequence located 5′ of the transcription start site was defined as promoter sequence. Using PCR primers and the promoter as a template, truncations were made at the 5′ end of the promoter to determine minimal cis-acting enhancer sequence (see FIG. 2). The truncations were fused to the uidA gene, which encodes GUS. The fusion gene was inserted into a vector and transformed by standard methods of ballistic transformation into Nicotiana tabacum Burley 21.

[0074] GUS activity was assessed by dividing ...

example 2

Localization of Nic Gene Product Binding Site in NtOPT1 Promoter

[0075] The NtQPT1 promoter deletion series fused to the uidA reporter gene (encoding GUS) was transformed into nic− / nic− homozygous N. tabacum plants. R0 transformants having the transgenic DNA at a single locus were crossed with nic− / nic− or Nic+ / Nic+ homozygous plants to give homozygous (nic− / nic−) and heterozygous (Nic+ / nic−) progeny carrying the transgene (NtQPT1 promoter-GUS) at the same chromosomal location. GUS activity was quantified in multiple progeny from multiple, independent transformants and compared between Nic+ and nic− phenotypes (TABLE 1). Ratios greater than 1.5 were determined to contain the cis-acting elements responding to Nic gene product activation.

TABLE 1Regulation of NtQPT1 Promoter-Directed GUS Expression by the NicGene Products in Tobacco.Inde-pendentGUSGUSTrans-activity inactivity inGUS ratioPromoterformantsNic+ / nic−2nic− / nic−2of Nic / nic2.0 (2010)12111.7(7)21.2(5)5.346.6(6)11.9(8)5.61.3 (...

example 3

Regulation of NtOPT1 Gene Expression Using Molecular Decoys

[0077] Nucleotide sequence located between −1000 and −600 or −700 bp of the NtQPT1 promoter is inserted in tandem arrays into a plant-Agrobacterium shuttle vector and subsequently transformed into tobacco via methods known to one skilled in the art. Plants stably transformed with said vector are assessed for the level of expression of NtQPT1 and for nicotine and / or TSNA content. These experiments will demonstrate that tobacco transformed with molecular decoys that interact with Nic gene products will exhibit a reduced amount of nicotine and / or TSNA. Plants with multiple tandem insertions of the molecular decoy which have reduced NtQPT1 expression and reduced nicotine levels are used for expression of commercially valuable products and production of tobacco products having reduced nicotine and / or TSNA content.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
nucleic acid constructaaaaaaaaaa
nucleic acidaaaaaaaaaa
Login to view more

Abstract

The present application describes isolated nucleic acids that contain a Nic gene product responsive element, and the use thereof in methods of producing transgenic tobacco plants having reduced levels of nicotine and / or TSNA therein, as well as other plants or host cells that contain altered levels of a protein of interest therein due to inclusion of a cis-acting decoy element therein.

Description

RELATED APPLICATIONS [0001] This application claims the benefit of provisional application Ser. No. 60 / 229,198, filed Aug. 30, 2000, the disclosure of which is incorporated by reference herein in its entirety.FIELD OF THE INVENTION [0002] The present invention describes a process for the production of transgenic plants such as transgenic tobacco plants with altered protein content therein, leading to altered phenotypes such as reduced nicotine levels, along with transgenic plants so produced and seed for such plants. BACKGROUND OF THE INVENTION [0003] The production of tobacco with decreased levels of nicotine is of interest, given concerns regarding the addictive nature of nicotine. Additionally, tobacco plants with extremely low levels of nicotine production, or no nicotine production, are attractive as recipients for transgenes expressing commercially valuable products such as pharmaceuticals, cosmetic components, or food additives. Various processes have been designed for the re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/82C12N5/10A01H5/00C12N1/15C12N1/19C12N1/21C12N9/10C12N15/09C12N15/29
CPCC07K14/415C12N9/1077C12N15/8216C12N15/8222C12N15/8257C12N15/8227C12N15/8243C12N15/8251C12N15/8223C12N15/11
Inventor CONKLING, MARKLI, YAN
Owner CONKLING MARK
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap